Effectiveness of a Visual Biofeedback Program Versus Conventional Physiotherapy on Shoulder Mobility, Strength, and Function in Women After Breast Cancer Surgery
NCT07542106
Summary
This study aims to evaluate the effectiveness of a physiotherapy program incorporating visual biofeedback compared to a conventional physiotherapy program in improving shoulder function in women following breast cancer surgery. Breast cancer survivors frequently experience shoulder dysfunction, including reduced range of motion, decreased strength, altered neuromuscular activity, and impaired scapulohumeral control. While conventional physiotherapy is effective, there is growing interest in interventions targeting motor control and neuromuscular coordination through biofeedback strategies. Participants will be randomly assigned to either a control group receiving conventional physiotherapy or an experimental group receiving the same program supplemented with visual biofeedback using the MotionGuidance system. Outcomes will include shoulder strength, range of motion, functional performance, electromyographic activity, and muscle oxygen saturation.
Eligibility
Inclusion Criteria: * Women aged 18 years or older * History of breast cancer surgery (mastectomy or breast-conserving surgery within the last 6 months) * Presence of shoulder pain, reduced range of motion, strength deficit, or functional limitation * Ability to understand and follow study instructions Exclusion Criteria: * Presence of metastasis * Post-surgical complications contraindicating exercise * Severe lymphedema (Stage III or IV) * Neurological disorders affecting the upper limb * Severe musculoskeletal shoulder conditions unrelated to breast cancer * Participation in other rehabilitation programs
Conditions3
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
NCT07542106